Yann Herault – Modelling the 17q21.31 syndromes in mouse improves our knowledge on the contribution of Kansl1 to the disease

Max Planck Seminar

Date: Apr 26, 2017
Time: 01:00 PM c.t. - 02:00 PM (Local Time Germany)
Speaker: Yann Herault
L'institut de génétique et de biologie moléculaire et cellulaire (IGBMC), Strasbourg, France
Location: MPI-IE
Room: Main Lecture Hall
Host: Asifa Akhtar

Yann Herault – Modelling the 17q21.31 syndromes in mouse improves our knowledge on the contribution of Kansl1 to the disease

Dr. Yann Hérault is a Research Director at the French National Centre for Scientific Research (CNRS). The Biologist and mouse geneticist is leading the Mouse Clinical Institute and a research group on “Physiopathology of aneuploidy, gene dosage effect and Down syndrome” at the IGBMC, Strasbourg. He will visit the institute in April, 26th 2017. The title of his talk will be announced soon. The talk takes place in the Main Lecture Hall at 1pm.

Yann Herault obtained his Ph.D. at the University of Lyon, France and was in the following Post-Doc at the University of Geneva, Switzerland from 1993 to 1999. In 2000 Yann Herault joined the Institute de Transgenose in Orleans, France as a group leader. There he was further the director of the infrastructure for Transgenesis and Archiving of Animal Models (TAAM) from 2007-2014. He developed CELPHEDIA the National Infrastructure for model animal in the French roadmap for Infrastructure (2008-present). Since 2010 Yann Herault is group leader at the IGBMC, Strasbourg, France.

Research

He and his team in the lab on “Translational medicine and neurogenetics” are interested on evaluating the consequences of gene dosage effect and copy number variation in pathological situation such as in Down Syndrome (or Trisomy 21) to further propose new therapeutic approaches.

sources: linkedin, labpage